These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 18795964

  • 1. Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: the Swiss HIV Cohort Study.
    Bellini C, Keiser O, Chave JP, Evison J, Fehr J, Kaiser L, Weber R, Vernazza P, Bernasconi E, Telenti A, Cavassini M, Swiss HIV Cohort Study.
    HIV Med; 2009 Jan; 10(1):12-8. PubMed ID: 18795964
    [Abstract] [Full Text] [Related]

  • 2. Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy.
    Matthews GV, Bartholomeusz A, Locarnini S, Ayres A, Sasaduesz J, Seaberg E, Cooper DA, Lewin S, Dore GJ, Thio CL.
    AIDS; 2006 Apr 04; 20(6):863-70. PubMed ID: 16549970
    [Abstract] [Full Text] [Related]

  • 3. Chronic active hepatitis B exacerbations in human immunodeficiency virus-infected patients following development of resistance to or withdrawal of lamivudine.
    Bessesen M, Ives D, Condreay L, Lawrence S, Sherman KE.
    Clin Infect Dis; 1999 May 04; 28(5):1032-5. PubMed ID: 10452630
    [Abstract] [Full Text] [Related]

  • 4. [Patients co-infected with HIV and hepatitis-B virus (HBV): the favourable effect of lamivudine, as part of combined antiretroviral therapy, on HBV may be dependent upon the number of CD4-cells].
    Smit MC, Haverkamp MH, Weersink AJ, Boucher CA, Hoepelman IM.
    Ned Tijdschr Geneeskd; 2004 Nov 20; 148(47):2330-4. PubMed ID: 15587052
    [Abstract] [Full Text] [Related]

  • 5. Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study.
    Sheng WH, Hung CC, Kao JH, Chang SY, Chen MY, Hsieh SM, Chen PJ, Chang SC.
    Clin Infect Dis; 2007 Apr 01; 44(7):988-95. PubMed ID: 17342655
    [Abstract] [Full Text] [Related]

  • 6. Do HIV care providers appropriately manage hepatitis B in coinfected patients treated with antiretroviral therapy?
    Jain MK, Opio CK, Osuagwu CC, Pillai R, Keiser P, Lee WM.
    Clin Infect Dis; 2007 Apr 01; 44(7):996-1000. PubMed ID: 17342656
    [Abstract] [Full Text] [Related]

  • 7. Impact of hepatitis B virus co-infection on response to highly active antiretroviral treatment and outcome in HIV-infected individuals: a nationwide cohort study.
    Omland LH, Weis N, Skinhøj P, Laursen A, Christensen PB, Nielsen HI, Møller A, Engsig F, Sørensen HT, Obel N.
    HIV Med; 2008 May 01; 9(5):300-6. PubMed ID: 18400077
    [Abstract] [Full Text] [Related]

  • 8. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.
    Sullivan PS, Hanson DL, Teshale EH, Wotring LL, Brooks JT.
    AIDS; 2006 May 12; 20(8):1171-9. PubMed ID: 16691069
    [Abstract] [Full Text] [Related]

  • 9. Occult hepatitis B infection in patients infected with HIV: report of two cases of hepatitis B reactivation and prevalence in a hospital cohort.
    Bloquel B, Jeulin H, Burty C, Letranchant L, Rabaud C, Venard V.
    J Med Virol; 2010 Feb 12; 82(2):206-12. PubMed ID: 20029819
    [Abstract] [Full Text] [Related]

  • 10. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.
    Cohen Stuart JW, Velema M, Schuurman R, Boucher CA, Hoepelman AI.
    J Med Virol; 2009 Mar 12; 81(3):441-5. PubMed ID: 19152397
    [Abstract] [Full Text] [Related]

  • 11. Frequent occurrence of chronic hepatitis B virus infection among West African HIV type-1-infected children.
    Rouet F, Chaix ML, Inwoley A, Anaky MF, Fassinou P, Kpozehouen A, Rouzioux C, Blanche S, Msellati P, Programme Enfant Yopougon (Agence Nationale de Recherches sur le SIDA et les Hépatites Virales B et C 1244/1278).
    Clin Infect Dis; 2008 Feb 01; 46(3):361-6. PubMed ID: 18171303
    [Abstract] [Full Text] [Related]

  • 12. Treatment of chronic hepatitis B in HIV co-infected patients.
    Guan R.
    Med J Malaysia; 2005 Jul 01; 60 Suppl B():52-6. PubMed ID: 16108174
    [Abstract] [Full Text] [Related]

  • 13. Lamivudine useful against hepatitis B-HIV co-infection.
    Prescott LM.
    J Int Assoc Physicians AIDS Care; 1995 Jun 01; 1(5):34. PubMed ID: 11362610
    [Abstract] [Full Text] [Related]

  • 14. Reconstitution of hepatitis B virus (HBV)-specific T cell responses with treatment of human immunodeficiency virus/HBV coinfection.
    Lascar RM, Gilson RJ, Lopes AR, Bertoletti A, Maini MK.
    J Infect Dis; 2003 Dec 15; 188(12):1815-9. PubMed ID: 14673759
    [Abstract] [Full Text] [Related]

  • 15. Lopinavir/ritonavir treatment in HIV antiretroviral-experienced patients: evaluation of risk factors for liver enzyme elevation.
    Meraviglia P, Schiavini M, Castagna A, Viganò P, Bini T, Landonio S, Danise A, Moioli MC, Angeli E, Bongiovanni M, Hasson H, Duca P, Cargnel A.
    HIV Med; 2004 Sep 15; 5(5):334-43. PubMed ID: 15369508
    [Abstract] [Full Text] [Related]

  • 16. Immune reconstitution hepatitis in HIV and hepatitis B coinfection, despite lamivudine therapy as part of HAART.
    Drake A, Mijch A, Sasadeusz J.
    Clin Infect Dis; 2004 Jul 01; 39(1):129-32. PubMed ID: 15206064
    [Abstract] [Full Text] [Related]

  • 17. Opportunistic infections update.
    Proj Inf Perspect; 1998 Dec 01; (26):5-6. PubMed ID: 11366497
    [Abstract] [Full Text] [Related]

  • 18. Risk factors for acute liver enzyme abnormalities in HIV-hepatitis B virus-coinfected patients on antiretroviral therapy.
    Chauvel O, Lacombe K, Bonnard P, Lascoux-Combe C, Molina JM, Miailhes P, Girard PM, Carrat F.
    Antivir Ther; 2007 Dec 01; 12(7):1115-26. PubMed ID: 18018770
    [Abstract] [Full Text] [Related]

  • 19. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida.
    Enferm Infecc Microbiol Clin; 2009 Apr 01; 27(4):222-35. PubMed ID: 19246124
    [Abstract] [Full Text] [Related]

  • 20. Hepatitis B exacerbation with a precore mutant virus following withdrawal of lamivudine in a human immunodeficiency virus-infected patient.
    Neau D, Schvoerer E, Robert D, Dubois F, Dutronc H, Fleury HJ, Ragnaud JM.
    J Infect; 2000 Sep 01; 41(2):192-4. PubMed ID: 11023772
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.